US Stock MarketDetailed Quotes

MLTX MoonLake Immunotherapeutics

Watchlist
  • 44.700
  • -0.040-0.09%
Close Jul 22 16:00 ET
  • 44.700
  • 0.0000.00%
Post 16:01 ET
2.81BMarket Cap-62083P/E (TTM)

MoonLake Immunotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
53.27%19.82M
-16.81%54.12M
-9.99%15.03M
-12.14%12.98M
-25.30%13.19M
-18.89%12.93M
65.06M
16.7M
135.68%14.77M
-45.99%17.65M
Selling and administrative expenses
23.38%6.81M
-3.00%22.32M
30.11%6.93M
-6.17%5.39M
-28.31%4.48M
0.53%5.52M
--23.01M
--5.33M
2.65%5.75M
122.10%6.25M
-General and administrative expense
23.38%6.81M
-3.00%22.32M
30.11%6.93M
-6.17%5.39M
-28.31%4.48M
0.53%5.52M
--23.01M
--5.33M
2.65%5.75M
122.10%6.25M
Research and development costs
75.51%13.01M
-24.37%31.8M
-28.77%8.1M
-15.95%7.59M
-23.65%8.7M
-29.08%7.42M
--42.05M
--11.37M
1,247.88%9.02M
-61.83%11.4M
Operating profit
-53.27%-19.82M
16.81%-54.12M
9.99%-15.03M
12.14%-12.98M
25.30%-13.19M
18.89%-12.93M
-65.06M
-16.7M
-135.68%-14.77M
45.99%-17.65M
Net non-operating interest income expense
Other net income (expense)
717.48%5.92M
1,613.34%10.14M
2,900.28%7.19M
3,587.69%1.39M
243.76%842.65K
941.05%723.59K
591.73K
239.51K
280.39%37.59K
6,584.92%245.13K
Other non- operating income (expenses)
717.48%5.92M
1,613.34%10.14M
2,900.28%7.19M
3,587.69%1.39M
243.76%842.65K
941.05%723.59K
--591.73K
--239.51K
280.39%37.59K
6,584.92%245.13K
Income before tax
-13.90%-13.91M
31.77%-43.98M
52.34%-7.84M
21.33%-11.59M
29.09%-12.34M
23.09%-12.21M
-64.47M
-16.46M
-134.30%-14.73M
46.74%-17.41M
Income tax
538.07%70.25K
159.55%94.39K
302.36%44.31K
230.93%28.92K
9.34%10.15K
50.16%11.01K
36.37K
11.01K
8.74K
9.28K
Net income
-14.38%-13.98M
31.67%-44.08M
52.10%-7.89M
21.18%-11.62M
29.07%-12.35M
23.05%-12.22M
-64.51M
-16.47M
-134.44%-14.74M
46.72%-17.42M
Net income continuous Operations
-14.38%-13.98M
31.67%-44.08M
52.10%-7.89M
21.18%-11.62M
29.07%-12.35M
23.05%-12.22M
---64.51M
---16.47M
-134.44%-14.74M
46.72%-17.42M
Minority interest income
90.61%-301.87K
44.46%-8.07M
-170.37%-450.31K
52.64%-2.19M
58.19%-2.21M
-3.21M
-14.53M
639.89K
-4.63M
-5.3M
Net income attributable to the parent company
-51.85%-13.67M
27.95%-36.01M
56.53%-7.44M
6.77%-9.43M
16.35%-10.14M
43.29%-9M
-49.97M
-17.11M
-60.79%-10.11M
62.92%-12.12M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-51.85%-13.67M
27.95%-36.01M
56.53%-7.44M
6.77%-9.43M
16.35%-10.14M
43.29%-9M
-49.97M
-17.11M
-60.79%-10.11M
62.92%-12.12M
Basic earnings per share
4.35%-0.22
57.06%-0.73
67.74%-0.1
33.33%-0.18
32.35%-0.23
46.52%-0.23
-1.7
-0.31
-58.55%-0.27
61.59%-0.34
Diluted earnings per share
4.35%-0.22
57.06%-0.73
67.74%-0.1
33.33%-0.18
32.35%-0.23
46.52%-0.23
-1.7
-0.31
-58.55%-0.27
61.59%-0.34
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 53.27%19.82M-16.81%54.12M-9.99%15.03M-12.14%12.98M-25.30%13.19M-18.89%12.93M65.06M16.7M135.68%14.77M-45.99%17.65M
Selling and administrative expenses 23.38%6.81M-3.00%22.32M30.11%6.93M-6.17%5.39M-28.31%4.48M0.53%5.52M--23.01M--5.33M2.65%5.75M122.10%6.25M
-General and administrative expense 23.38%6.81M-3.00%22.32M30.11%6.93M-6.17%5.39M-28.31%4.48M0.53%5.52M--23.01M--5.33M2.65%5.75M122.10%6.25M
Research and development costs 75.51%13.01M-24.37%31.8M-28.77%8.1M-15.95%7.59M-23.65%8.7M-29.08%7.42M--42.05M--11.37M1,247.88%9.02M-61.83%11.4M
Operating profit -53.27%-19.82M16.81%-54.12M9.99%-15.03M12.14%-12.98M25.30%-13.19M18.89%-12.93M-65.06M-16.7M-135.68%-14.77M45.99%-17.65M
Net non-operating interest income expense
Other net income (expense) 717.48%5.92M1,613.34%10.14M2,900.28%7.19M3,587.69%1.39M243.76%842.65K941.05%723.59K591.73K239.51K280.39%37.59K6,584.92%245.13K
Other non- operating income (expenses) 717.48%5.92M1,613.34%10.14M2,900.28%7.19M3,587.69%1.39M243.76%842.65K941.05%723.59K--591.73K--239.51K280.39%37.59K6,584.92%245.13K
Income before tax -13.90%-13.91M31.77%-43.98M52.34%-7.84M21.33%-11.59M29.09%-12.34M23.09%-12.21M-64.47M-16.46M-134.30%-14.73M46.74%-17.41M
Income tax 538.07%70.25K159.55%94.39K302.36%44.31K230.93%28.92K9.34%10.15K50.16%11.01K36.37K11.01K8.74K9.28K
Net income -14.38%-13.98M31.67%-44.08M52.10%-7.89M21.18%-11.62M29.07%-12.35M23.05%-12.22M-64.51M-16.47M-134.44%-14.74M46.72%-17.42M
Net income continuous Operations -14.38%-13.98M31.67%-44.08M52.10%-7.89M21.18%-11.62M29.07%-12.35M23.05%-12.22M---64.51M---16.47M-134.44%-14.74M46.72%-17.42M
Minority interest income 90.61%-301.87K44.46%-8.07M-170.37%-450.31K52.64%-2.19M58.19%-2.21M-3.21M-14.53M639.89K-4.63M-5.3M
Net income attributable to the parent company -51.85%-13.67M27.95%-36.01M56.53%-7.44M6.77%-9.43M16.35%-10.14M43.29%-9M-49.97M-17.11M-60.79%-10.11M62.92%-12.12M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -51.85%-13.67M27.95%-36.01M56.53%-7.44M6.77%-9.43M16.35%-10.14M43.29%-9M-49.97M-17.11M-60.79%-10.11M62.92%-12.12M
Basic earnings per share 4.35%-0.2257.06%-0.7367.74%-0.133.33%-0.1832.35%-0.2346.52%-0.23-1.7-0.31-58.55%-0.2761.59%-0.34
Diluted earnings per share 4.35%-0.2257.06%-0.7367.74%-0.133.33%-0.1832.35%-0.2346.52%-0.23-1.7-0.31-58.55%-0.2761.59%-0.34
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg